2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) a report of the American …
TW Rooke, AT Hirsch, S Misra, AN Sidawy… - Circulation, 2011 - Am Heart Assoc
The results of late-breaking clinical trials presented at the annual scientific meetings of the
ACC, AHA, European Society of Cardiology, Society for Vascular Surgery, Society of …
ACC, AHA, European Society of Cardiology, Society for Vascular Surgery, Society of …
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
and pulmonary embolism (PE), occurs in∼ 1 to 2 individuals per 1000 each year …
and pulmonary embolism (PE), occurs in∼ 1 to 2 individuals per 1000 each year …
2017 cardiovascular and stroke endpoint definitions for clinical trials
This publication describes uniform definitions for cardiovascular and stroke outcomes
developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the …
developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the …
[HTML][HTML] Protected carotid-artery stenting versus endarterectomy in high-risk patients
Background Carotid endarterectomy is more effective than medical management in the
prevention of stroke in patients with severe symptomatic or asymptomatic atherosclerotic …
prevention of stroke in patients with severe symptomatic or asymptomatic atherosclerotic …
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific …
Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
[HTML][HTML] Stenting and medical therapy for atherosclerotic renal-artery stenosis
Background Atherosclerotic renal-artery stenosis is a common problem in the elderly.
Despite two randomized trials that did not show a benefit of renal-artery stenting with respect …
Despite two randomized trials that did not show a benefit of renal-artery stenting with respect …
[HTML][HTML] Surgery or endovascular therapy for chronic limb-threatening ischemia
Background Patients with chronic limb-threatening ischemia (CLTI) require revascularization
to improve limb perfusion and thereby limit the risk of amputation. It is uncertain whether an …
to improve limb perfusion and thereby limit the risk of amputation. It is uncertain whether an …
A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism …
G Piazza, B Hohlfelder, MR Jaff, K Ouriel… - Cardiovascular …, 2015 - jacc.org
Objectives This study conducted a prospective, single-arm, multicenter trial to evaluate the
safety and efficacy of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis, using …
safety and efficacy of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis, using …
2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart …
KA Hicks, JE Tcheng, B Bozkurt, BR Chaitman… - Circulation, 2015 - Am Heart Assoc
This publication, commissioned by the ACC/AHA, is the product of a novel collaboration
between the ACC and AHA, the US Food and Drug Administration (FDA), and the …
between the ACC and AHA, the US Food and Drug Administration (FDA), and the …
Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT …
JR Laird, BT Katzen, D Scheinert… - Circulation …, 2010 - Am Heart Assoc
Background—Controversy still exists regarding the best endovascular treatment strategy for
patients with symptomatic disease of the superficial femoral artery. There are conflicting data …
patients with symptomatic disease of the superficial femoral artery. There are conflicting data …